
Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.360
Open
2.330
VWAP
--
Vol
42.69M
Mkt Cap
72.43B
Low
2.300
Amount
--
EV/EBITDA(TTM)
13.26
Total Shares
15.75B
EV
397.04B
EV/OCF(TTM)
14.93
P/S(TTM)
--
Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces, distributes and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company's activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El Salvador, Honduras, Nicaragua, Barbados and Panama; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile; and Canada, represented by Labatt’s operations, which comprises sales in Canada and some exports to the U.S. market. The Company markets products under various brand names, such as Adriatica, Brahma, Leffe, Budweiser, Corona, PepsiCo and Lipton. It is a subsidiary of Interbrew International BV.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
21.35B
+6.49%
0.036
+36.9%
23.30B
+5.43%
0.042
+10.96%
27.74B
+2.62%
0.063
+17.85%
Estimates Revision
The market is revising Downward the revenue expectations for Ambev S.A. (ABEV) for FY2025, with the revenue forecasts being adjusted by -0.33% over the past three months. During the same period, the stock price has changed by -9.09%.
Revenue Estimates for FY2025
Revise Downward

-0.33%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+1.07%
In Past 3 Month
Stock Price
Go Down

-9.09%
In Past 3 Month
3 Analyst Rating

30.43% Upside
Wall Street analysts forecast ABEV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ABEV is 3.00 USD with a low forecast of 2.50 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
0 Sell
Moderate Buy

30.43% Upside
Current: 2.300

Low
2.50
Averages
3.00
High
4.00

30.43% Upside
Current: 2.300

Low
2.50
Averages
3.00
High
4.00
UBS
Neutral
maintain
2025-06-04
Reason
UBS
Price Target
2025-06-04
maintain
Neutral
Reason
UBS raised the firm's price target on Ambev to $2.70 from $2.60 and keeps a Neutral rating on the shares.
Barclays
Equal Weight
maintain
$2
2025-05-12
Reason
Barclays
Price Target
$2
2025-05-12
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Ambev to $2.50 from $2 and keeps an Equal Weight rating on the shares. While Ambev has begun to set itself up to "combat" upcoming margin pressures in the coming quarters, in Q1 the company saw better than expected volumes, the analyst tells investors in a research note.
UBS
Rodrigo Alcantara
Strong Buy
to
Hold
Downgrades
n/a
2025-04-22
Reason
UBS
Rodrigo Alcantara
Price Target
n/a
2025-04-22
Downgrades
Strong Buy
to
Hold
Reason
UBS downgraded Ambev to Neutral from Buy with a R$16 price target. Given the 20% year-to-date return, the analyst sees a more balanced risk/reward at current levels.
Citigroup
Renata Cabral
Strong Buy
to
Hold
Downgrades
n/a
2025-01-22
Reason
Citigroup
Renata Cabral
Price Target
n/a
2025-01-22
Downgrades
Strong Buy
to
Hold
Reason
Barclays
Benjamin Theurer
Hold
Maintains
$2.5 → $2
2025-01-21
Reason
Barclays
Benjamin Theurer
Price Target
$2.5 → $2
2025-01-21
Maintains
Hold
Reason
Barclays analyst Benjamin Theurer lowered the firm's price target on Ambev to $2 from $2.50 and keeps an Equal Weight rating on the shares. Entering 2025, the firm is more optimistic about crop protection and maintains a positive outlook on diversified international protein names and ingredients. In contrast, Barclays adds caution to its grain processor coverage and adjusted ratings in fertilizer given the recent run-up in share prices. It recognizes the strength in potash volumes in 2024 did not bring stock appreciation for the major potash players.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Ambev SA (ABEV.N) is 12.24, compared to its 5-year average forward P/E of 17.22. For a more detailed relative valuation and DCF analysis to assess Ambev SA 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
17.22
Current PE
12.24
Overvalued PE
21.34
Undervalued PE
13.10
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
8.47
Current EV/EBITDA
6.15
Overvalued EV/EBITDA
10.27
Undervalued EV/EBITDA
6.68
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued
5Y Average PS
2.81
Current PS
2.13
Overvalued PS
3.40
Undervalued PS
2.23
Financials
Annual
Quarterly
FY2025Q1
YoY :
+10.95%
22.50B
Total Revenue
FY2025Q1
YoY :
+16.91%
5.73B
Operating Profit
FY2025Q1
YoY :
+0.01%
3.80B
Net Income after Tax
FY2025Q1
YoY :
0.00%
0.23
EPS - Diluted
FY2025Q1
YoY :
-226.24%
375.82M
Free Cash Flow
FY2025Q1
YoY :
+1.91%
51.35
Gross Profit Margin - %
FY2025Q1
YoY :
-5.21%
24.02
FCF Margin - %
FY2025Q1
YoY :
-9.86%
16.91
Net Margin - %
FY2025Q1
YoY :
-7.64%
16.69
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 9796.69% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
1.4M
Volume
2
6-9
Months
14.2K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
4.2M
Volume
Months
6-9
3
7.9M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
40.0K
USD
5
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
2
16.0K
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ABEV News & Events
News
3.0
06-14BenzingaLatin America's Hot Stocks: 3 NYSE Picks To Dodge Trade Wars, Mideast Mayhem
7.0
06-04BenzingaUS Aluminum Tariffs Risk Supply Chain And Food Security, Industry Insiders Warn
6.0
05-12BenzingaBarclays Maintains Equal-Weight on Ambev, Raises Price Target to $2.5
Sign Up For More News
People Also Watch

ASND
Ascendis Pharma A/S
166.780
USD
+2.12%

SNV
Synovus Financial Corp
47.840
USD
-2.57%

CAE
CAE Inc
28.600
USD
+0.18%

GIL
Gildan Activewear Inc
51.630
USD
-0.52%

IVZ
Invesco Ltd
21.480
USD
-1.10%

DLB
Dolby Laboratories Inc
75.730
USD
-0.47%

TREX
Trex Company Inc
66.230
USD
-1.41%

CHRD
Chord Energy Corp
111.900
USD
-1.95%

MIDD
Middleby Corp
144.680
USD
-1.54%

PAAS
Pan American Silver Corp
27.370
USD
-3.56%
FAQ

What is Ambev SA (ABEV) stock price today?
The current price of ABEV is 2.3 USD — it has decreased -1.71 % in the last trading day.

What is Ambev SA (ABEV)'s business?

What is the price predicton of ABEV Stock?

What is Ambev SA (ABEV)'s revenue for the last quarter?

What is Ambev SA (ABEV)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Ambev SA (ABEV)'s fundamentals?

How many employees does Ambev SA (ABEV). have?
